DK3733171T3 - Sammensætninger omfattende hmb og atp samt anvendelse deraf - Google Patents
Sammensætninger omfattende hmb og atp samt anvendelse deraf Download PDFInfo
- Publication number
- DK3733171T3 DK3733171T3 DK20169493.2T DK20169493T DK3733171T3 DK 3733171 T3 DK3733171 T3 DK 3733171T3 DK 20169493 T DK20169493 T DK 20169493T DK 3733171 T3 DK3733171 T3 DK 3733171T3
- Authority
- DK
- Denmark
- Prior art keywords
- atp
- compositions including
- including hmb
- hmb
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261698919P | 2012-09-10 | 2012-09-10 | |
| EP13835631.6A EP2892522A4 (en) | 2012-09-10 | 2013-09-10 | HMB AND ATP COMPOSITION AND METHODS OF USE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3733171T3 true DK3733171T3 (da) | 2024-01-29 |
Family
ID=50237697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK20169493.2T DK3733171T3 (da) | 2012-09-10 | 2013-09-10 | Sammensætninger omfattende hmb og atp samt anvendelse deraf |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10092590B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2892522A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6258943B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN105025891B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2013312113B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112015005199B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2884405C (cg-RX-API-DMAC7.html) |
| DK (1) | DK3733171T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2970283T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI3733171T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE065064T2 (cg-RX-API-DMAC7.html) |
| PL (1) | PL3733171T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT3733171T (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014040067A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2018014407A (es) * | 2016-05-25 | 2019-02-21 | Tsi Group Ltd | Estabilizacion de formulaciones de acido beta-hidroxiisovalerico en capsulas de gel blando. |
| US10888576B2 (en) * | 2018-10-08 | 2021-01-12 | Metabolic Technologies, Inc. | Composition of HMB and ATP and methods of use |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5028440A (en) | 1990-01-30 | 1991-07-02 | Iowa State University Research Foundation, Inc. | Method of raising meat producing animals to increase lean tissue development |
| US4992470A (en) | 1990-02-08 | 1991-02-12 | Iowa State University Research Foundation, Inc. | Method of enhancing immune response of mammals |
| CA2142314C (en) | 1992-09-16 | 1999-06-01 | Steven L. Nissen | Method of reducing blood levels of total cholesterol and low-density lipoprotein cholesterol |
| US5348979A (en) | 1992-12-23 | 1994-09-20 | Iowa State University Research Foundation Inc. | Method of promoting nitrogen retention in humans |
| US6031000A (en) | 1998-06-23 | 2000-02-29 | Iowa State University Research Foundation, Inc. | Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use |
| JP4010390B2 (ja) * | 1999-09-20 | 2007-11-21 | 明治乳業株式会社 | 免疫賦活化組成物 |
| US7629329B2 (en) * | 2001-06-04 | 2009-12-08 | Tsi Health Sciences, Inc. | Method for increasing muscle mass and strength through administration of adenosine triphosphate |
| US20050027005A1 (en) * | 2003-08-02 | 2005-02-03 | Matthias Boldt | Nutrient compositions and methods for sustenance and promotion of positive metabolic energy levels in a targeted manner |
| US20050215640A1 (en) * | 2004-03-26 | 2005-09-29 | Baxter Jeffrey H | HMB compositions and uses thereof |
| US20060083793A1 (en) * | 2004-09-29 | 2006-04-20 | Gardiner Paul T | Nutritional composition for promoting muscle performance and acting as hydrogen (H+) blocker |
| US20060073891A1 (en) * | 2004-10-01 | 2006-04-06 | Holt Timothy M | Display with multiple user privacy |
| KR101299885B1 (ko) * | 2005-05-27 | 2013-08-23 | 코와 가부시키가이샤 | 피로 회복을 위한 의약 |
| WO2007108071A1 (ja) * | 2006-03-17 | 2007-09-27 | Pharma Foods International Co., Ltd. | 抗ストレス組成物及びそれを含有する飲食品 |
| PL2381784T3 (pl) * | 2008-12-09 | 2019-01-31 | Metabolic Technologies, Inc. | Interwencyjny produkt odżywczy w celu poprawy funkcji i siły mięśni |
| DE102009052640A1 (de) | 2009-11-10 | 2011-05-12 | Linde-Lkca-Dresden Gmbh | Verfahren und Vorrichtung zur Gaswäsche |
| WO2011075741A1 (en) * | 2009-12-18 | 2011-06-23 | Metabolic Technologies, Inc. | Improved method of administering beta-hydroxy-beta-methylbutyrate (hmb) |
-
2013
- 2013-09-10 ES ES20169493T patent/ES2970283T3/es active Active
- 2013-09-10 AU AU2013312113A patent/AU2013312113B2/en active Active
- 2013-09-10 PT PT201694932T patent/PT3733171T/pt unknown
- 2013-09-10 DK DK20169493.2T patent/DK3733171T3/da active
- 2013-09-10 WO PCT/US2013/059039 patent/WO2014040067A1/en not_active Ceased
- 2013-09-10 CN CN201380058560.6A patent/CN105025891B/zh active Active
- 2013-09-10 BR BR112015005199-5A patent/BR112015005199B1/pt active IP Right Grant
- 2013-09-10 FI FIEP20169493.2T patent/FI3733171T3/fi active
- 2013-09-10 CA CA2884405A patent/CA2884405C/en active Active
- 2013-09-10 PL PL20169493.2T patent/PL3733171T3/pl unknown
- 2013-09-10 EP EP13835631.6A patent/EP2892522A4/en not_active Ceased
- 2013-09-10 JP JP2015531321A patent/JP6258943B2/ja active Active
- 2013-09-10 HU HUE20169493A patent/HUE065064T2/hu unknown
- 2013-09-10 EP EP20169493.2A patent/EP3733171B1/en active Active
- 2013-09-10 US US14/023,162 patent/US10092590B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2884405A1 (en) | 2014-03-13 |
| EP2892522A1 (en) | 2015-07-15 |
| ES2970283T3 (es) | 2024-05-27 |
| JP2015527408A (ja) | 2015-09-17 |
| EP3733171A1 (en) | 2020-11-04 |
| EP2892522A4 (en) | 2016-01-20 |
| JP6258943B2 (ja) | 2018-01-10 |
| EP3733171B1 (en) | 2023-10-25 |
| AU2013312113B2 (en) | 2018-08-02 |
| BR112015005199A2 (pt) | 2017-07-04 |
| CA2884405C (en) | 2021-03-30 |
| PL3733171T3 (pl) | 2024-03-18 |
| CN105025891B (zh) | 2020-01-21 |
| BR112015005199B1 (pt) | 2022-09-06 |
| US10092590B2 (en) | 2018-10-09 |
| FI3733171T3 (fi) | 2024-01-24 |
| AU2013312113A1 (en) | 2015-03-26 |
| US20140080781A1 (en) | 2014-03-20 |
| HUE065064T2 (hu) | 2024-05-28 |
| WO2014040067A1 (en) | 2014-03-13 |
| HK1217087A1 (zh) | 2016-12-23 |
| CN105025891A (zh) | 2015-11-04 |
| PT3733171T (pt) | 2024-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3608325T3 (da) | Polycykliske-carbamoylpyridonforbindelser og deres farmaceutiske anvendelse | |
| DK2903600T3 (da) | Virusholdig formulering og anvendelse deraf | |
| DK3074027T3 (da) | Synergistiske bakteriesammensætninger og fremgangsmåder til fremstilling og anvendelse heraf | |
| HRP20182037T1 (hr) | Inhibitori prmt5 i njihova uporaba | |
| DK2872419T3 (da) | Fordelingsbeholder og tilsvarende fremgangsmåde | |
| DK2968443T3 (da) | Hepcidinanaloger og anvendelser deraf | |
| DK3043784T3 (da) | Arylethere og anvendelser deraf | |
| PT3066201T (pt) | Métodos e composições relacionadas com crispr com arng reguladores | |
| DK2970132T3 (da) | Argininmethyltransferaseinhibitorer og anvendelser deraf | |
| DK3381917T3 (da) | Imidazopyridinforbindelser og anvendelser deraf | |
| DK2850202T3 (da) | Fremgangsmåder og grupper | |
| DK3077467T3 (da) | Sikkativsammensætning og anvendelse deraf | |
| BR112014000049A2 (pt) | pirrolotriazinas substituídas com hidroximelilarilo e sua utilização | |
| IL237421A0 (en) | Topical compositions and methods of use | |
| DK2962100T3 (da) | Tuberkulosebiomarkører og anvendelser deraf | |
| DK2917181T3 (da) | Heteroarylderivater og anvendelser deraf | |
| EP2983661A4 (en) | FORMULATIONS OF OXABICYCLOHEPTANES AND OXABICYCLOHENDS | |
| HRP20181291T1 (hr) | Heterobicikloarilni inhibitori rorc2 i njihova upotreba | |
| DK3326642T3 (da) | Langtidsvirkende koagulationsfaktorer og brugen deraf | |
| DK3029038T3 (da) | Tetrazolinonforbindelse og anvendelse deraf | |
| DK2986618T3 (da) | Organiske anion-lithium-ion-co-krystalforbindelser og sammensætninger | |
| DK2956471T3 (da) | Il-1beta-hæmmersammensætning og anvendelse deraf | |
| DK2938186T3 (da) | Organ- og vævsbevaringsformuleringer med øget stabilitet og holdbarhed | |
| ME03029B (me) | Kompozicije koje obuhvataju vortioksetin i donepezil | |
| CL2015000638A1 (es) | Composiciones herbicidas que contienen aminopiralid y triclopir |